Is it all MIS-C? Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children after SARS-CoV-2 infection

Is it all MIS-C? Unusual findings in a series of nine German patients with multi-system inflammatory syndrome in children after SARS-CoV-2 infection

Objectives: Multi-system inflammatory syndrome in children (MIS-C) is a post-viral inflammatory vasculopathy of children and adolescents following Covid-19 infection. Since the incidence of SARS-CoV-infections has been increasing in Germany since October 2020, we observe an increasing number of chil...

Full description

Bibliographic Details
Main Authors:	Katrin Mehler, Norma Jung, Andre Oberthuer
Format:	Article
Language:	English
Published:	Elsevier 2021-05-01
Series:	International Journal of Infectious Diseases
Subjects:	MIS-C PIMS SARS-CoV-2 infection Children COVID-19
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971221003556

Similar Items

Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 Treated with Tocilizumab
by: Carmen Niño-Taravilla, et al.
Published: (2020-12-01)

Manifestations of the pediatric multisystem inflammatory syndrome temporally related with SARS-CoV-2 (PIMS) in the gastrointestinal, cardiovascular, nervous and respiratory systems.
by: Anna Brzyska, et al.
Published: (2022-04-01)

B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)
by: Adam Klocperk, et al.
Published: (2023-10-01)

The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis
by: Mohamad Hamad Saied, et al.
Published: (2023-08-01)

Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)
by: Susanna Felsenstein, et al.
Published: (2020-10-01)

Review of available therapies for the treatment of pediatric COVID-19-associated polyarticular inflammatory syndrome
by: Michał Leśniewski
Published: (2024-02-01)

Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes
by: Mônica O. Santos, et al.
Published: (2022-07-01)

Association of Ethnicity With Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2 Infection: An International Case-Referent Study
by: Judith G. Middelburg, et al.
Published: (2021-10-01)

“Multisystem Inflammatory Syndrome in Children”-Like Disease after COVID-19 Vaccination (MIS-V) with Potential Significance of Functional Active Autoantibodies Targeting G-Protein-Coupled Receptors (GPCR-fAAb) for Pathophysiology and Therapy
by: Marius Schmidt, et al.
Published: (2023-11-01)

Role of Lung Ultrasonography (LUS) as a Tool for Evaluating Children with Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS)
by: Jolanta Tomczonek-Moruś, et al.
Published: (2023-04-01)

Approach to a child with Multisystem Inflammatory Syndrome associated with COVID19. Recommendations by the Polish Paediatric Society Expert Group. Update – February 2021
by: Magdalena Okarska-Napierała, et al.
Published: (2021-07-01)

Multisystem inflammatory syndrome in children (MIS-C) and the coronavirus pandemic: Current knowledge and implications for public health
by: Megan S. Rafferty, et al.
Published: (2021-04-01)

A tendency to worse course of multisystem inflammatory syndrome in children with obesity: MultiOrgan Inflammatory Syndromes COVID-19 related study
by: Aneta Monika Gawlik, et al.
Published: (2022-09-01)

Anti-SARS-CoV-2 Vaccination and PIMS-TS—Friends or Foe? Case Reports and Literature Review
by: Violetta Opoka-Winiarska, et al.
Published: (2024-03-01)

Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children – a cross-sectional observational study from southern India.
by: Aishwarya Venkataraman, et al.
Published: (2021-04-01)

Elevated risk for psychiatric outcomes in pediatric patients with Multisystem Inflammatory Syndrome (MIS-C): A review of neuroinflammatory and psychosocial stressors
by: Tracy Pan, et al.
Published: (2024-07-01)

PIMS - symptoms and short/long-term gastrointestinal and cardiovascular system complications
by: Aleksandra Grudzińska, et al.
Published: (2023-03-01)

Pediatric inflammatory multisystem syndrome temporally associated with COVID-19 – a novel condition in children and adolescents
by: Małgorzata Wieteska, et al.
Published: (2021-07-01)

Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
by: Megan Striha, et al.
Published: (2021-11-01)

Polymorphism of clinical manifestations, experience of diagnosis and treatment of multisystem inflammatory syndrome associated with COVID-19 in children
by: L.V. Pypa, et al.
Published: (2022-12-01)

Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation
by: Serafina Perrone, et al.
Published: (2022-10-01)

Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia
by: Iveta Racko, et al.
Published: (2021-06-01)

Pediatric Inflammatory Multisystem Syndrome Temporally Related With SARS-CoV-2: Immunological Similarities With Acute Rheumatic Fever and Toxic Shock Syndrome
by: Danilo Buonsenso, et al.
Published: (2020-09-01)

Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
by: Dominic Worku
Published: (2023-03-01)

Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome
by: Piotr Buda, et al.
Published: (2022-09-01)

Family Transmission of COVID-19 Including a Child with MIS-C and Acute Pancreatitis
by: Abbas M, et al.
Published: (2021-02-01)

Clinical profile of SARS-CoV-2 infection-associated pediatric Multisystem Inflammatory Syndrome (MIS-C): A case series from Western Maharashtra
by: Vipulkumar V Gandhi, et al.
Published: (2022-01-01)

MULTISYSTEM-INFLAMMATORY SYNDROME (MIS-C) IN NEONATE ASSOCIATED WITH SARS-COVID19
by: Yerdan Mukhaliyev, et al.
Published: (2022-06-01)

MULTISYSTEM-INFLAMMATORY SYNDROME (MIS-C) IN NEONATE ASSOCIATED WITH SARS-COVID19
by: Yerdan Mukhaliyev, et al.
Published: (2022-06-01)

Tocilizumab: alternativa terapéutica en el síndrome inflamatorio multisistémico pediátrico
by: Ana Gallego-Tapia, et al.
Published: (2023-01-01)

Analysis of the impact of the SARS-CoV-2 infection on the pediatric population hospitalized during the pandemic in the Greater Paris University Hospitals
by: Michaela Semeraro, et al.
Published: (2023-02-01)

The Youngest Palestinian Case of Multisystem Inflammatory Syndrome in children (MIS-C)
by: Fawzy Mazen Abunejma, et al.
Published: (2022-12-01)

SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report from Iraq
by: Ruwaid Behnam Y. Al-Simaani, et al.
Published: (2023-09-01)

Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Prenatal Maternal SARS-CoV-2: A Case Series
by: Ravindra Pawar, et al.
Published: (2021-07-01)

Multisystem inflammatory syndrome in children associated with Bacille Calmette-Guérin scar: a case presentation
by: Hilal Kizildag, et al.
Published: (2023-03-01)

The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis
by: Maitray A. Patel, et al.
Published: (2024-04-01)

Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register
by: Magdalena Okarska-Napierała, et al.
Published: (2020-10-01)

Anakinra in pediatric acute fulminant myocarditis
by: Louise Maunier, et al.
Published: (2022-08-01)

Targeting Pim kinases in hematological cancers: molecular and clinical review
by: Marcia Bellon, et al.
Published: (2023-01-01)

Mis huacos (some fragments)
by: Martín García Mérou
Published: (2023-03-01)